ALLMedicine™ Nephrocalcinosis Center
Research & Reviews 393 results
https://doi.org/10.1007/s40620-022-01369-y 10.36141/svdld.v37i2.9142 10.3389/fimmu.2020.537382 10.1016/j.rmed.2021.106548 10.1097/MCP.0000000000000715 10.1186/s12931-018-0871-3 10.1016/S2213-2600(20)30105-3 10.1097/MCP.0000000000000504 10.1097/MCP.0000000000000800 10.1186/s12890-016-0332-z 10.1007/s00408-019-00243-2 10.1038/s41572-019-0096-x 10.1016/j.rmed.2020.106161 10.1097/MCP.0000000000000719 10.1016/j.rmed.2018.11.022 10.1097/MCP.0000000000000305 10.3389/fimmu.2020.00474 10.1038/cmi.2016.45 10.1183/13993003.00119-2019 10.1111/j.1600-065X.2008.00718.x 10.1016/j.molimm.2004.06.040 10.3390/ijms141121463 10.3390/ijms21197398 10.36141/svdld.v34i2.5369 10.2741/2692 10.1016/j.it.2020.01.007 10.1165/rcmb.2018-0053OC 10.4049/jimmunol.168.9.4620 10.1164/rccm.202002-0251ST 10.1016/S2213-2600(18)30064-X 10.1055/s-0040-1709495 10.1055/s-0040-1713615 10.12890/2021_002540 10.1097/CRD.0000000000000354 10.1016/j.cardfail.2021.06.016 10.1055/s-0040-1713130 10.23736/S2784-8671.21.07027-4 10.7759/cureus.1833 10.1016/j.autrev.2014.04.001 10.1080/25785826.2021.1940740 10.7759/cureus.10399 10.1155/2022/4657502 10.1055/s-0037-1602380 10.1186/s12931-020-1303-8 10.1177/106689690601400110 10.1097/MD.0b013e31819de50f 10.1038/ki.2010.89 10.1681/ASN.2008121226 10.1038/nri.2016.132 10.1159/000181783 10.1093/ndt/5.1.18 10.5414/cnp57142 10.1097/00007611-200406000-00016 10.1007/s10157-004-0294-y 10.1038/sj.ki.5001512 10.1053/j.ajkd.2011.09.025 10.1016/j.revmed.2012.10.009 10.1093/ckj/sfv053 10.11604/pamj.2015.22.75.6237 10.4103/1319-2442.215120 10.1136/bcr-2018-227023 10.1007/s13730-017-0287-9 10.1016/j.cca.2018.11.014 10.4103/1319-2442.292321 10.4103/1319-2442.284036 10.5414/CNP96S02 10.1159/000183258 10.1007/s13730-015-0171-4 10.1159/000046660 10.1093/ndt/18.2.280 10.2215/CJN.01790506 10.1053/j.ajkd.2016.05.004 10.1136/thoraxjnl-2021-218249 10.36141/svdld.v38i3.11488 10.1093/ndt/gft442 10.4103/1319-2442.275471 10.1097/RHU.0000000000001003 10.1007/s10157-010-0336-6 10.1159/000049044 10.1007/s13730-021-00660-4 10.15403/jgld.2014.1121.lil 10.1186/s13256-015-0764-8 10.1186/1750-1172-8-65 10.1093/ndt/gfv080 10.1093/med/9780198784081.001.0001 10.1136/thx.43.5.422 10.5414/cnp60284 10.1210/jc.2013-2016 10.1136/bcr-2015-210189 10.1210/er.2016-1070 10.1002/jbmr.2262 10.1515/jomb-2017-0041 10.1186/ar4568 10.1016/j.amjms.2016.05.027 10.1016/j.amjmed.2021.04.037 10.4103/0971-4065.116325 10.1016/j.amjmed.2021.06.023 10.1007/s11657-017-0360-1 10.1177/1078155213518361 10.1007/s13730-021-00643-5 10.1152/ajprenal.00038.2007 10.1371/journal.pone.0178872 10.1148/62.2.203 10.1136/pgmj.31.360.516 10.1016/0002-9343(56)90009-2 10.1016/s0022-5347(17)65251-0 10.1016/s0022-3476(05)80347-6 10.1093/ndt/12.10.2161 10.2147/TCRM.S83681 10.1007/s40620-019-00602-5 10.4158/ACCR-2020-0120 10.1016/j.juro.2012.11.069 10.1016/j.actbio.2018.01.040 10.1016/j.juro.2011.09.057 10.1038/nrneph.2016.101 10.1136/bcr-2013-010017 10.5414/cnp65449 10.1056/NEJM198108203050807 10.1053/sarh.2002.32548 10.1016/0002-9343(86)90828-4 10.1093/oxfordjournals.ndt.a092094 10.1016/s0272-6386(12)80961-9 10.1097/00007890-199911150-00033 10.1007/s00467-009-1137-6 10.1016/j.transproceed.2012.11.008 10.1371/journal.pone.0110778 10.1016/j.transproceed.2017.03.025 10.1007/s13730-018-0369-3 10.1055/s-0031-1298981 10.2215/CJN.03970510
Journal of Nephrology; Calatroni M, Moroni G et. al.
Jun 28th, 2022 - Sarcoidosis is a systemic inflammatory disease of unknown etiology. The pathogenesis rests on an aberrant T cell response to unidentified antigens in individuals predisposed by genetic and environmental factors. Increased expression of polarized m...
https://doi.org/10.1002/jbmr.4630
Journal of Bone and Mineral Research : the Official Journ... Stürznickel J, Heider F et. al.
Jun 12th, 2022 - Hereditary hypophosphatemic rickets with hypercalciuria (HHRH) represents an FGF23-independent disease caused by biallelic variants in the solute carrier family 34-member 3 (SLC34A3) gene. HHRH is characterized by chronic hypophosphatemia and an i...
https://doi.org/10.1007/s00240-022-01338-x 10.2215/CJN.07540715 10.1042/cs1030259 10.1111/j.1523-1755.2005.00170.x 10.1038/ki.2014.298 10.1016/j.ajhg.2010.07.023 10.1016/j.nephro.2016.08.002 10.1159/000086358 10.1159/000086357 10.1016/j.ijsu.2016.11.085 10.1007/s00240-017-0996-8 10.1007/s00439-019-01978-x 10.1038/ki.2011.336 10.1681/ASN.2014040388 10.1016/j.semnephrol.2021.05.002 10.20529/IJME.2022.006 10.1016/0277-9536(92)90147-I 10.1007/s12687-011-0072-y 10.1038/ki.2009.435 10.1111/j.1523-1755.2004.00842.x 10.1007/s00467-002-0977-0 10.1046/j.1523-1755.2001.00462.x 10.1681/ASN.2016030338 10.1093/ndt/gfr182
Urolithiasis Hashmi S, Abid A et. al.
Jun 10th, 2022 - Autosomal recessive disorders are prevalent in Pakistan, a developing South Asian country where consanguineous marriages are common. This study seeks to determine the prevalence of monogenic causes in children presenting with nephrocalcinosis and ...
https://doi.org/10.1002/mgg3.1992
Molecular Genetics & Genomic Medicine; Ahmed HA, Fadel FI et. al.
Jun 7th, 2022 - Primary hyperoxaluria (PH) is a rare heterogeneous, autosomal recessive disorder of glyoxylate metabolism. It is characterized by excessive hepatic production of oxalate resulting in a wide spectrum of clinical, imaging, and functional presentatio...
https://clinicaltrials.gov/ct2/show/NCT03742505
Jun 7th, 2022 - Rationale: Documented roles for vitamin D in calcium homeostasis, cardiovascular and respiratory health, innate immunity, and neuromuscular function have led to the hypothesis that vitamin D deficiency (VDD) represents a modifiable risk factor for...
Guidelines 1 results
https://doi.org/10.1093/ndt/gfs078
Nephrology, Dialysis, Transplantation : Official Publicat... Cochat P, Hulton SA et. al.
May 2nd, 2012 - Primary hyperoxaluria Type 1 is a rare autosomal recessive inborn error of glyoxylate metabolism, caused by a deficiency of the liver-specific enzyme alanine:glyoxylate aminotransferase. The disorder results in overproduction and excessive urinary...
Drugs 5 results see all →
Clinicaltrials.gov 39 results
https://clinicaltrials.gov/ct2/show/NCT03742505
Jun 7th, 2022 - Rationale: Documented roles for vitamin D in calcium homeostasis, cardiovascular and respiratory health, innate immunity, and neuromuscular function have led to the hypothesis that vitamin D deficiency (VDD) represents a modifiable risk factor for...
https://clinicaltrials.gov/ct2/show/NCT04119765
May 16th, 2022 - Hyperoxaluria due to fat malabsorption is seen in patients suffering from short bowel and can lead to stones and nephrocalcinosis. Not all patients are prone to these renal complications. only urinary oxaluria is measured in practice. Plasma oxala...
https://clinicaltrials.gov/ct2/show/NCT05343247
Apr 25th, 2022 - One of the developmental enamel defects, amelogenesis imperfecta (AI), is also known as enamel hypoplasia/hypomineralization. It is a rare inherited disease that affects the enamel structure, amount and component in primary and permanent teeth, an...
https://clinicaltrials.gov/ct2/show/NCT00566488
Apr 4th, 2022 - Detailed: DiGeorge Syndrome is a complex of three problems, 1) cardiac defects, 2) parathyroid deficiency, and 3) absence of the thymus, resulting in profound T-cell deficiency. There is a spectrum of disease in DiGeorge syndrome with respect to a...
https://clinicaltrials.gov/ct2/show/NCT00576836
Mar 25th, 2022 - DiGeorge anomaly is a congenital disorder in which infants are born with defects of the thymus, heart, and parathyroid gland. Complete DiGeorge Anomaly is usually fatal within the first two years of life. This trial evaluates the role of cultured ...
News 12 results
https://www.medscape.com/viewarticle/958630
Sep 13th, 2021 - Gene therapy, new therapeutics currently in clinical trials, and a promising dietary supplement are feeding the optimism of kidney stone expert Glenn Preminger, MD. Glenn Preminger "The future of kidney stones looks exceedingly bright," said Premi...
https://reference.medscape.com/viewarticle/843821
Feb 19th, 2021 - Editor's Note: The Case Challenge series includes difficult-to-diagnose conditions, some of which are not frequently encountered by most clinicians but are nonetheless important to accurately recognize. Test your diagnostic and treatment skills us...
https://www.medscape.com/viewarticle/941520
Nov 24th, 2020 - The US Food and Drug Administration (FDA) has approved lumasiran (Oxlumo, Alnylam Pharmaceuticals) subcutaneous injection to treat children and adults with primary hyperoxaluria type 1 (PH1), an ultra-rare genetic disorder that causes recurrent ki...
https://www.medscape.com/viewarticle/899201_2
Feb 21st, 2020 - Nephrocalcinosis is a condition characterized by the calcification of the renal tubules that leads to renal insufficiency. This occurs via metastatic calcification, which means that calcium is deposited in normal tissues, rather than those that ha...
https://www.medscape.com/viewarticle/858175
Feb 3rd, 2016 - NEW YORK (Reuters Health) - A young woman with end-stage nephrocalcinosis secondary to congenital absence of parathyroid glands has received a simultaneous living donor kidney and parathyroid gland transplant, Chicago-based researchers report. In ...